Klaus Poppensieker

Title: Klaus Poppensieker: Innovator in Medical Particle Acceleration

Introduction

Klaus Poppensieker is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of medical particle acceleration, holding a total of seven patents. His work focuses on improving the precision and effectiveness of ion beam irradiation techniques.

Latest Patents

Poppensieker's latest patents include an "Apparatus and method for compensation of movements of a target volume during ion beam irradiation." This invention addresses the challenges posed by three-dimensional movements of a target volume during treatment. The apparatus features a position location and tracking system to detect movements and a depth modulator to adjust the ion beam's penetration depth. The compensation process involves vectorially dividing movements into transverse and longitudinal components, ensuring accurate treatment delivery.

Another significant patent is the "Beam allocation apparatus and beam allocation method for medical particle accelerators." This invention manages multiple control rooms for different treatment and quality assurance rooms. It includes an arbitration unit with switching logic and a monitoring unit, along with a spill abort system that can halt ion beam irradiation within microseconds. This innovation enhances the safety and efficiency of medical particle accelerators.

Career Highlights

Klaus Poppensieker is associated with Gesellschaft für Schwerionenforschung mbH, where he continues to develop groundbreaking technologies in the field of medical physics. His work has been instrumental in advancing the capabilities of particle accelerators used in cancer treatment.

Collaborations

Poppensieker collaborates with esteemed colleagues such as Thomas Haberer and Eugen Badura, contributing to a dynamic research environment focused on innovative solutions in medical technology.

Conclusion

Klaus Poppensieker's contributions to medical particle acceleration through his patents and collaborative efforts highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cancer treatment technologies.